AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Pay a Past-Due Balance Join Our Mailing List

The Authors’ Own Words: Co-prescription of naloxone as a Universal Precautions model for patients on chronic opioid therapy—Observational study

by

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Co-prescription of naloxone as a Universal Precautions model for patients on chronic opioid therapy—Observational study
Mikiko Y. Takeda, Joanna G. Katzman, Ernest Dole, Melissa Heinz Bennett, Amal Alchbli, Daniel Duhigg & Howard Yonas
Substance Abuse Vol. 37 , Iss. 4,2016

Since opioid overdose death is such a pressing public health issue, harm reduction innovations to prevent overdose death are critical to study. The ambulatory co-prescribing of naloxone is a universal precaution model for all patients prescribed chronic opioid therapy. This can be adapted universally for all patients treated with chronic opioid therapy in an ambulatory setting so that there is increased availability and utilization in the case of an opioid overdose.

————————————————————————————————-
Our newly released issue is now online —> April-June 2017.
————————————————————————————————
–

Call for Papers Deadline Extension

by

We received a great Intent to Submit response for our recent Call for Papers and are in the process of seeing some of the manuscripts entering our online system.

To honor vacation season, we’ve decided to lengthen the deadline to next Friday, August 21.

If you have a paper that aligns with our theme of Implementation and Quality Improvement: Applying and Advancing Best Practices in Opioid Use Disorder Treatment, please send an Intent to Submit email to substanceabuseeditor@gmail.com by Friday, August 21st with the intended title and a brief description  of the intended work.

2018 Special Section Call for Papers – Intent to Submit Deadline Approaches

by

Our August 15th deadline for an Intent to Submit email is approaching for our 2018 Special Section. The topic is Implementation and Quality Improvement: Applying and Advancing Best Practices in Opioid Use Disorder Treatment. We’ve received a number of intent emails thus far and look forward to reviewing yours!

Topics of interest include:

  • Quality improvement in Opioid Overdose Education and Naloxone Distribution (OEND) programs, including linkage with OUD treatment
  • Innovations in clinical trial, epidemiology, health services, and translational addiction research
  • Implementation science research
  • Addiction program quality improvement
  • Addiction policy and education initiatives
  • Interdisciplinary research conducted by health professionals who are traditionally underrepresented in addiction research (e.g., pharmacists)

For full details, please view our Call for Papers:

thumbnail of Call for Papers PCSS-O 2017

 

As always, we welcome any questions – please email the Editor-in-Chief at substanceabuseeditor@gmail.com.

Seth Godin on What We Deserve

by

Seth Godin is a hero and mentor of Managing Editor Dan Harding.

Seth is an author, speaker, thought leader, and has been blogging daily insights for over 10 years.

A recent blog post nicely summarized why many of us do what we do with a fresh lens – a lens about what we deserve.

View the post here: http://sethgodin.typepad.com/seths_blog/2016/10/moral-hazard-is-no-excuse-for-our-inhumanity.html

————————————————————————————————-
Our newly released issue is now online —> October-December 2016.
————————————————————————————————-